Quec.li

everything quec.li

Merck's Keytruda helps lung cancer patients live longer in trial

[Reuters: Health News] Merck's Keytruda helps lung cancer patients live longer in trial: (Reuters) - Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its position as the dominant player in the lucrative lung cancer market.



    Return home.